Proposed Data Collections Submitted for Public Comment and Recommendations, 24045-24046 [05-9067]
Download as PDF
<![CDATA[
24045
Federal Register / Vol. 70, No. 87 / Friday, May 6, 2005 / Notices
collected; and (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology. Written comments should
be received within 60 days of this
notice.
Proposed Project
Twelve-Month Follow-up of Chronic
Fatigue Syndrome (CFS) and Chronic
Unwellness in Georgia—New —Centers
for Disease Control and Prevention
(CDC)—National Center for Infectious
Diseases (NCID).
Background and Brief Description
The Chronic Fatigue Syndrome
Program within the CDC has been
mandated by Congress to: (1) Estimate
the magnitude of CFS in the United
States with special consideration of
under-served populations (children and
racial/ethnic minorities); (2) describe
the clinical features of CFS; and (3)
additional longitudinal study will allow
CDC to estimate incidence of CFS,
chronic unwellness, and other fatiguerelated illnesses among various racial
and ethnic populations and characterize
the clinical course of these conditions.
CDC will compare prevalence and
incidence estimates from this proposed
study of the Georgia population to
estimates obtained from the longitudinal
Sedgwick County Studies of CFS to
ascertain whether or not findings from
the Sedgwick County Studies can be
generalized to other populations.
The proposed study continues the
initial Georgia survey using similar
methodology and data collection
instruments. This follow-up study will
begin with a detailed telephone
interview to obtain additional data on
participant health status during the last
twelve-month period. Eligible subjects
will be asked to participate in clinical
evaluations. There is no cost to
respondents other than their time. The
total annualized burden hours are 2228.
identify risk factors and diagnostic
markers. CDC is currently planning a
twelve-month follow-up study in
Georgia to estimate the prevalence and
incidence of CFS and other fatiguing
illnesses. The study will also determine
whether or not there are differences in
occurrence of fatiguing illness across
metropolitan, urban, and rural
populations as well as in racial and
ethnic populations.
In 2004, OMB approved the
information collection, Survey of
Chronic Fatigue Syndrome and Chronic
Unwellness in Georgia, under OMB
Number 0920–0638, which provides
baseline information on prolonged
fatiguing illness in selected
metropolitan, urban, and rural regions
in Georgia. Data from the proposed
Follow-up Survey of Chronic Fatigue
Syndrome and Chronic Unwellness in
Georgia, will be added to the baseline
data obtained under OMB Number
0920–0638, which cover the period
September 2004–June 2005. This
ESTIMATE OF ANNUALIZED BURDEN TABLE
Respondents
Number of
respondents
Number
responses per
respondent
Average burden/response
(in hours)
Total burden
hours
Telephone interview .........................................................................................
4,455
1
30/60
2228
Dated: April 29, 2005.
Joan F. Karr,
Acting Reports Clearance Officer, Centers for
Disease Control and Prevention.
[FR Doc. 05–9066 Filed 5–5–05; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–05–05BW]
Proposed Data Collections Submitted
for Public Comment and
Recommendations
In compliance with the requirement
of section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for
opportunity for public comment on
proposed data collection projects, the
Centers for Disease Control and
Prevention (CDC) will publish periodic
summaries of proposed projects. To
request more information on the
proposed projects or to obtain a copy of
the data collection plans and
instruments, call 404–371–5983 or send
comments to Seleda Perryman, CDC
Assistant Reports Clearance Officer,
VerDate jul<14>2003
18:03 May 05, 2005
Jkt 205001
1600 Clifton Road, MS–D74, Atlanta,
GA 30333 or send an e-mail to
omb@cdc.gov.
Comments are invited on: (a) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information to be
collected; and (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology. Written comments should
be received within 60 days of this
notice.
Proposed Project
Survey of Primary Care Physicians
Regarding Prostate Cancer Screening—
New—National Center for Chronic
Disease Prevention and Health
Promotion (NCCDPHP), Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
Prostate cancer is the most common
cancer in men and is the second leading
PO 00000
Frm 00085
Fmt 4703
Sfmt 4703
cause of cancer deaths, behind lung
cancer, in the United States. The
American Cancer Society estimates that
there will be about 232,090 new cases
of prostate cancer and about 30,350
deaths in 2005. Although prostate
cancer deaths have declined over the
past several years, it ranks fifth among
deaths from all causes.
The Digital Rectal Examination (DRE)
and Prostate Specific Antigen (PSA) test
are used to screen for prostate cancer.
Screening is controversial and many are
not in agreement as to whether the
potential benefits of screening outweigh
the risks, that is, if PSA based screening,
early detection, and treatment increases
longevity. Although major medical
organizations are divided on whether
men should be routinely screened for
this disease, it appears that all of the
major organizations recommend
discussion with patients about the
benefits and risks of screening.
The purpose of this project is to
develop and administer a national
survey to a sample of American primary
care physicians to examine whether or
not they: (1) Screen for prostate cancer
using PSA and/or DRE, (2) recommend
testing and under what conditions, (3)
discuss the tests and the risks and
benefits of screening with patients, and
E:\FR\FM\06MYN1.SGM
06MYN1
24046
Federal Register / Vol. 70, No. 87 / Friday, May 6, 2005 / Notices
(4) use screening practices that vary by
factors such as age, ethnicity, and family
history of the patient. This study will
also examine the demographic, social,
and behavioral characteristics of
physicians as they relate to screening of
similar issues and participate in shared
decision-making between the physician
and the patient.
There will be no cost to respondents
other than their time.
ESTIMATE OF ANNUALIZED BURDEN HOURS
Average burden per response
(in hours)
Number of respondents
Number of responses per
respondents
Primary Care Physician ...................................................................................
1,500
1
40/60
1,000
Total ..........................................................................................................
1,500
........................
........................
1,000
Respondents
Dated: April 29, 2005.
Joan F. Karr,
Acting Reports Clearance Officer, Centers for
Disease Control and Prevention.
[FR Doc. 05–9067 Filed 5–5–05; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–05–05CC]
Proposed Data Collections Submitted
for Public Comment and
Recommendations
In compliance with the requirement
of section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for
opportunity for public comment on
proposed data collection projects, the
Centers for Disease Control and
Prevention (CDC) will publish periodic
summaries of proposed projects. To
request more information on the
proposed projects or to obtain a copy of
the data collection plans and
instruments, call 404–371–5983 and
send comments to Seleda Perryman,
CDC Assistant Reports Clearance
Officer, 1600 Clifton Road, MS–D74,
Atlanta, GA 30333 or send an e-mail to
omb@cdc.gov.
Comments are invited on: (a) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information to be
collected; and (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology. Written comments should
be received within 60 days of this
notice.
Total burden
(in hours)
Background and Brief Description
The National Center for Health
Statistics collects data through a number
of on-going person-based and facilitybased surveys. Among the major ongoing surveys are the National Health
Interview Survey (0920–0214) and the
National Health and Nutrition
Examination Survey (0920–0237). Due
mainly to budgetary restraints, critical
surveys such as the National Survey of
Family Growth (0920–0314) and the
National Survey of Hospice and Home
Health Care (0920–0298) are not in the
field continuously.
This new activity will allow pilot and
field testing of planned surveys, most of
which have received past OMB
approval, resulting in enhanced
knowledge and refined accuracy prior to
requesting full OMB clearance. Some of
the activities envisioned include: (1)
The ability to measure the changes in
technology in facility record keeping; (2)
to test the feasibility of using improved
information technology in data
collection; and (3) to test new
methodologies for obtaining sensitive
information from individuals.
There is no cost to respondents other
than their time to participate.
Proposed Project
Pilot and Field Testing to Assist with
the Planning of NCHS Data
Collections—New—National Center for
Health Statistics (NCHS), Centers for
Disease Control and Prevention (CDC).
ESTIMATE OF ANNUALIZED BURDEN HOURS
Number of
respondents
Respondents
Number of
responses per
respondent
Average
burden per
response
(in hours)
Total burden
hours
Facility interview ..............................................................................................
Household/in-person interview ........................................................................
300
200
2
1
1.0
30/60
600
100
Total burden .............................................................................................
........................
........................
........................
700
VerDate jul<14>2003
18:03 May 05, 2005
Jkt 205001
PO 00000
Frm 00086
Fmt 4703
Sfmt 4703
E:\FR\FM\06MYN1.SGM
06MYN1
]]>Agencies
[Federal Register Volume 70, Number 87 (Friday, May 6, 2005)]
[Notices]
[Pages 24045-24046]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-9067]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60Day-05-05BW]
Proposed Data Collections Submitted for Public Comment and
Recommendations
In compliance with the requirement of section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for opportunity for public comment on
proposed data collection projects, the Centers for Disease Control and
Prevention (CDC) will publish periodic summaries of proposed projects.
To request more information on the proposed projects or to obtain a
copy of the data collection plans and instruments, call 404-371-5983 or
send comments to Seleda Perryman, CDC Assistant Reports Clearance
Officer, 1600 Clifton Road, MS-D74, Atlanta, GA 30333 or send an e-mail
to omb@cdc.gov.
Comments are invited on: (a) Whether the proposed collection of
information is necessary for the proper performance of the functions of
the agency, including whether the information shall have practical
utility; (b) the accuracy of the agency's estimate of the burden of the
proposed collection of information; (c) ways to enhance the quality,
utility, and clarity of the information to be collected; and (d) ways
to minimize the burden of the collection of information on respondents,
including through the use of automated collection techniques or other
forms of information technology. Written comments should be received
within 60 days of this notice.
Proposed Project
Survey of Primary Care Physicians Regarding Prostate Cancer
Screening--New--National Center for Chronic Disease Prevention and
Health Promotion (NCCDPHP), Centers for Disease Control and Prevention
(CDC).
Background and Brief Description
Prostate cancer is the most common cancer in men and is the second
leading cause of cancer deaths, behind lung cancer, in the United
States. The American Cancer Society estimates that there will be about
232,090 new cases of prostate cancer and about 30,350 deaths in 2005.
Although prostate cancer deaths have declined over the past several
years, it ranks fifth among deaths from all causes.
The Digital Rectal Examination (DRE) and Prostate Specific Antigen
(PSA) test are used to screen for prostate cancer. Screening is
controversial and many are not in agreement as to whether the potential
benefits of screening outweigh the risks, that is, if PSA based
screening, early detection, and treatment increases longevity. Although
major medical organizations are divided on whether men should be
routinely screened for this disease, it appears that all of the major
organizations recommend discussion with patients about the benefits and
risks of screening.
The purpose of this project is to develop and administer a national
survey to a sample of American primary care physicians to examine
whether or not they: (1) Screen for prostate cancer using PSA and/or
DRE, (2) recommend testing and under what conditions, (3) discuss the
tests and the risks and benefits of screening with patients, and
[[Page 24046]]
(4) use screening practices that vary by factors such as age,
ethnicity, and family history of the patient. This study will also
examine the demographic, social, and behavioral characteristics of
physicians as they relate to screening of similar issues and
participate in shared decision-making between the physician and the
patient.
There will be no cost to respondents other than their time.
Estimate of Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Respondents Number of responses per per response Total burden
respondents respondents (in hours) (in hours)
----------------------------------------------------------------------------------------------------------------
Primary Care Physician.......................... 1,500 1 40/60 1,000
-----------------
Total....................................... 1,500 .............. .............. 1,000
----------------------------------------------------------------------------------------------------------------
Dated: April 29, 2005.
Joan F. Karr,
Acting Reports Clearance Officer, Centers for Disease Control and
Prevention.
[FR Doc. 05-9067 Filed 5-5-05; 8:45 am]
BILLING CODE 4163-18-P
